Daniel Vargas

M.Sc. in Chemical Sciences with more than three years of research experience in medicinal and organometallic chemistry focused on the design, synthesis and analytical characterization of compounds with potential anticancer activity. Experienced in multidisciplinary research integrating synthetic chemistry, molecular docking, analytical development and advanced characterization techniques, including HPLC, Mass Spectrometry, NMR, FT-IR, UV-Vis spectroscopy and electrochemistry. Additionally, one year of pharmaceutical industry experience performing analytical testing, impurity profiling and stability studies under FEUM, USP, EP and ALCOA+ requirements.

Seeking opportunities in Research & Development, Drug Discovery, Analytical Development and Scientific Innovation within pharmaceutical, biotechnology and healthcare organizations.

M.Sc. Researcher at Institute of Chemistry, UNAM (2024-02 – 2026-05)

• Rationally designed and synthesized two novel cyclometalated ruthenium complexes as potential anticancer agents, supporting structure-activity relationship and mechanistic studies.
• Performed analytical characterization through NMR, Mass Spectrometry, FT-IR, UV-Vis spectroscopy and electrochemistry for structural elucidation.
• Applied experimental strategies to investigate structure-property relationships and support mechanistic studies.
• Conducted organometallic synthesis under inert atmosphere using Schlenk techniques.
• Implemented laboratory inventory systems and equipment verification aligned with GLP.
• Mentored undergraduate researchers and provided technical guidance in laboratory activities.

Quality Control Analyst at Laboratorio de Control ARJ (2023-02 – 2024-01)

• Released more than 500 pharmaceutical batches through assay testing and impurity profiling using HPLC.
• Performed analytical testing under FEUM, USP and EP requirements.
• Participated in investigation and resolution of analytical deviations (OOS/OOT) through root cause analysis and corrective actions.
• Evaluated pharmaceutical stability studies according to NOM-073.
• Generated technical documentation following ALCOA+ data integrity principles.
• Worked with multiple pharmaceutical dosage forms including injectables, tablets, capsules, creams, gels and suspensions.

Undergraduate Researcher at Faculty of Chemistry, UNAM (2021-02 – 2022-12)

• Designed, synthesized and evaluated eight quinazoline derivatives with potential anticancer activity.
• Integrated computational chemistry through molecular docking to predict biological activity.
• Performed analytical characterization and interpretation of experimental results.
• Presented research findings at the SERMACS-iRIPs 2022 in Puerto Rico.

M.Sc. in Chemical Sciences – Institute of Chemistry, UNAM (2024 – 2026)

B.Sc. in Chemistry – Faculty of Chemistry, UNAM (2017 – 2022)